Lv61
3140 积分 2022-08-07 加入
Long-term efficacy and safety of JAKi in refractory livedoid vasculopathy
27分钟前
待确认
Long-term efficacy and safety of JAKi in refractory livedoid vasculopathy
39分钟前
已关闭
The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban
42分钟前
已完结
Real‐world data on pain management and effectiveness of anti‐tumour necrosis factor agents in refractory livedoid vasculopathy
49分钟前
已完结
Long-Term Efficacy of Guideline-Followed Treatment in Patients with Livedoid Vasculopathy: A Single-Center Study
52分钟前
已完结
Long-Term Efficacy of Guideline-Followed Treatment in Patients with Livedoid Vasculopathy: A Single-Center Study
52分钟前
已关闭
Long-Term Efficacy of Guideline-Followed Treatment in Patients with Livedoid Vasculopathy: A Single-Center Study
53分钟前
已关闭
A novel combination (“CHAP”) regimen for management of livedoid vasculopathy in 12 patients
1小时前
已完结
Refractory livedoid vasculopathy successfully treated with baricitinib
1小时前
已完结
Peripheral neuropathy and livedoid vasculopathy
1小时前
已完结
皖公网安备34019202002308
